Prosthetic valvular hemolysis: a potential pitfall in the routine use of serum lactate dehydrogenase as tumor marker in patients with germ cell testicular tumors.
Leibovitch
Ilan
I
Department of Urology, Meir Medical Center, Kfar Saba, Israel. leibovitchi@clalit.org.il
Veinreb
Michael
M
Sterenberg
Itay
I
Alkalay
Reuben
R
D014408:Biomarkers, Tumor / Q000097:blood*; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006461:Hemolysis; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009373:Neoplasms, Germ Cell and Embryonal / Q000097:blood / Q000473:pathology*; D011379:Prognosis; D013736:Testicular Neoplasms / Q000097:blood / Q000473:pathology*
D014408:Biomarkers, Tumor; D007770:L-Lactate Dehydrogenase